Guidelines for managing high blood pressure

All of RECERCAT

To access the full text documents, please follow this link: http://hdl.handle.net/2445/120333

dc.contributor	Universitat de Barcelona
dc.contributor.author	Morales-Salinas, Alberto
dc.contributor.author	Coca, Antonio
dc.contributor.author	Wyss, Fernando Stuardo
dc.date	2018-02-28T13:00:38Z
dc.date	2018-02-28T13:00:38Z
dc.date	2014-07-16
dc.date	2018-02-28T13:00:38Z
dc.identifier.citation	0098-7484
dc.identifier.citation	655824
dc.identifier.uri	http://hdl.handle.net/2445/120333
dc.format	2 p.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	American Medical Association
dc.relation	Reproducció del document publicat a: https://doi.org/10.1001/jama.2014.6590
dc.relation	JAMA-Journal of the American Medical Association, 2014, vol. 312, num. 3, p. 293-294
dc.relation	https://doi.org/10.1001/jama.2014.6590
dc.rights	(c) American Medical Association, 2014
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Normes
dc.subject	Pressió sanguínia
dc.subject	Medicaments
dc.subject	Standards
dc.subject	Blood pressure
dc.subject	Drugs
dc.title	Guidelines for managing high blood pressure
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.abstract	Guidelines for Managing High Blood Pressure To the Editor Someevidence against β-blockers1 has been published in recent years; however, the exclusion of these drugs as initial treatment of uncomplicated hypertension in the report fromthe panelmembersappointed to the Eighth Joint National Committee (JNC 8)2 is surprising...